DUNCAN MCLAREN
CEO
Mr. Mclaren has an eighteen-year proven track record of creating and scaling technology and health businesses. Among those accomplishments, in 2014 he co-founded MyGiHealth; a platform that has revolutionized the way that doctors and patients communicate to facilitate better health outcomes. Mr. Mclaren has hands on experience accelerating the identification and randomization of patients into clinical trials. Mr. Mclaren has been a board member of Digestive Health Associates since 2017, an organization dedicated to improved gastrointestinal health.
Mr. McLaren holds a BSc in Oceanography from the University of Southampton and a MBA in Business Administration from San Diego State University.
BILL ALBRO
Co-Founder
Mr. Albro is a respected pharmaceutical executive with over 15 years in the industry. He brings domain expertise to the table with his background as a formulation scientist. In addition, Mr. Albro has extensive experience managing inter-disciplinary drug discovery teams. Most recently, Mr. Albro has served as a Strategic Leader at companies such as ThermoFisher Scientific and Merck KGA.
Mr. Albro has a Bachelors of Science in Biology from Fairfield University and a MBA in Management from Rensselaer Polytechnic Institute.
ADVISORY BOARD
DR. JUNE CHIN, MD
CHIEF MEDICAL ADVISOR
Dr. Chin has been an advocate for better understanding of the science and medicine of marijuana and has been profiled for her work in St. Jude’s Medical, Columbia Business School, NYTimes, LA Times, Forbes, Huff Post and USA TODAY. Her book, ”Cannabis and CBD for Health and Wellness” was published in June 2019. In 2020. She joined the board of The American Academy of Cannabinoid Medicine which is the gold standard for the education and dissemination of clinically relevant information in the emerging field of cannabinoid medicine. Dr. Chin is also the Chief Medical Advisor of Bloom Farms and Artemis CBD Shop.
Dr. Chin holds a degree in Biochemistry and Nutritional Sciences from Cornell University, Business Innovation in Global Healthcare from Harvard Business School, Medical Acupuncture from Harvard Business School and Exercise Physiology from New York University. She received her M.D. in Osteopathic Medicine from Touro University California.
JACQUELYN E. BRIGGS, ESQ.
REGULATORY AFFAIRS ADVISOR
Ms. Briggs, currently Senior Counsel for Boehringer Ingelheim, has held various in-house counsel positions for both public and private pharmaceutical companies with a focus primarily on regulatory, contract and corporate law. She is also a part-time faculty member at Northeastern University where she lectures on a variety of regulatory affairs topics with an emphasis on FDA law, industry related contracts, protocol design and optimization as well as laboratory management.
Ms. Briggs holds Bachelors of Science in Biology from The University of Massachusetts Dartmouth, a Master of Science in Regulatory Affairs from Northeastern University, a Juris Doctor from the University of Massachusetts School of Law and a mini-MBA in Biopharma Innovation from Rutgers Business School.
ROGER COE
CORPORATE ADVISOR
Mr. Coe is President of Briggs Capital Advisors and has over 35 years of capital markets experience as an executive with leading investment banking firms as well as privately advising on numerous family office accounts. Mr. Coe has participated in hundreds of principal transactions and has managed numerous venture capital, institutional and banking relationships on behalf of dozens of CEO. Over a 25-year period. Mr. Coe was primary financial advisor to one of the pioneers of the venture capital industry in connection with day to day management and trading responsibilities for a diversified securities portfolio aggregating more than $400 million. Mr. Coe’s sales experience spans multiple industries including technology, consumer, biotech and healthcare. Mr.Coe was Managing Director and head of the Corporate Executive Services for CIBC/Oppenheimer in Boston.